Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference14 articles.
1. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci 1999;96: 15268–15273.
2. Lynch B, Lambeng N, Nocka K, et al. The Synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Roc Natl Acad Sci 2004;101: 9861–9866.
3. Kenda BM, Matagne AC, Talaga PE, Pasau PM, Differding E, Lallemand BI, et al. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. Journal of Medicinal Chemistry 2004;47: 530–549.
4. Zona C, Pieri M, Klitgaard H, Margineanu D-G. ucb 34714, a new pyrrolidone derivative, inhibits Na+-currents in rat cortical neurons in culture. Epilepsia 2004;45(suppl 7): 146.
5. Margineanu D-G, Kenda BM, Michel P, Matagne AC, Klitgaard H. ucb 34714, a new pyrrolidone derivative: comparison with levetiracetam in hippocampal slice epilepsy models in vitro. Epilepsia 2003;44(suppl 9): 261.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献